Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
EMBO Mol Med. 2021 Oct 7;13(10):e13790. doi: 10.15252/emmm.202013790. Epub 2021 Sep 6.
Alopecia induced by aging or side effects of medications affects millions of people worldwide and impairs the quality of life; however, there is a limit to the current medications. Here, we identify a small transdermally deliverable 5-mer peptide (GLYYF; P5) that activates adiponectin receptor 1 (AdipoR1) and promotes hair growth. P5 sufficiently reproduces the biological effect of adiponectin protein via AMPK signaling pathway, increasing the expression of hair growth factors in the dermal papilla cells of human hair follicle. P5 accelerates hair growth ex vivo and induces anagen hair cycle in mice in vivo. Furthermore, we elucidate a key spot for the binding between AdipoR1 and adiponectin protein using docking simulation and mutagenesis studies. This study suggests that P5 could be used as a topical peptide drug for alleviating pathological conditions, which can be improved by adiponectin protein, such as alopecia.
衰老或药物副作用引起的脱发影响着全世界数百万人,并降低了他们的生活质量;然而,目前的药物治疗有一定的局限性。在这里,我们发现了一种可经皮传递的 5 肽(GLYYF;P5),它可以激活脂联素受体 1(AdipoR1)并促进头发生长。P5 通过 AMPK 信号通路充分再现了脂联素蛋白的生物学效应,增加了人毛囊真皮乳头细胞中头发生长因子的表达。P5 在体外加速了毛发生长,并在体内诱导了小鼠的生长期。此外,我们通过对接模拟和突变研究阐明了 AdipoR1 与脂联素蛋白结合的关键位点。这项研究表明,P5 可以作为一种局部肽类药物,用于缓解脂联素蛋白等可以改善的病理性脱发等疾病。